A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.

SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft ...

Scientists from Tomsk Polytechnic University, in collaboration with their colleagues, have successfully determined the impact ...

Pune: A 45-year-old woman from Satara recently underwent a dual procedure in the city to treat two rare conditions: a recurring tumour of the abdomina.

As NUCATS continues to champion translational research, grants like the Giddan Award ensure that pediatric health research ...